Commission adopted a proposal for a new Directive and a new Regulation,
which revise and replace the existing general pharmaceutical
legislation. (...)
The revision aims to achieve the following main objectives:
- Make sure all patients across the EU have timely and equitable access to safe, effective, and affordable medicines
- Enhance the security of supply and ensure medicines are available to patients, regardless of where they live in the EU
- Continue to offer an attractive and innovation-friendly environment for research, development, and production of medicines in Europe
- Make medicines more environmentally sustainable
- Address antimicrobial resistance (AMR) and the presence of pharmaceuticals in the environment through a One Health approach. (...)
Post
Nessun commento:
Posta un commento